Plain-English translation of NCT06589830 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new drug called TL938 to see if it works better when given alone or combined with (a medication already used to treat certain cancers) in patients with advanced colorectal cancer that has spread. The study will enroll about 80 people and test different doses of the medication to find the safest and most effective approach.
Most people with advanced colorectal cancer have already tried several standard treatments without success. This study exists because researchers believe this new medication may help patients whose cancer has stopped responding to other therapies.
You likely qualify if…
You likely don't qualify if…
You will take by mouth once daily and may also receive intravenously (through an IV) on the first day of each 21-day treatment cycle, depending on which group you're assigned to. You will have regular clinic visits for blood tests, imaging scans, and check-ups to monitor how well the treatment is working and watch for side effects.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China